The Defense Production Act has historically allowed the US to prioritize American needs in times of crisis. In an abrupt shift, the Biden administration will allow shipments of raw materials for the manufacture of COVID-19 vaccines to India, explains Matt Kavanagh, an assistant professor of global health at Georgetown University.